Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AveXis’ Zolgensma gene therapy yields desired results in SMA trials
AveXis’ Zolgensma gene therapy delivers rapid, significant, clinically meaningful benefit in spinal muscular atrophy. (Credit: Darwin Laganzon from Pixabay)
AveXis’ Zolgensma gene therapy delivers rapid, significant, clinically meaningful benefit in spinal muscular atrophy. (Credit: Darwin Laganzon from Pixabay)